These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
757 related items for PubMed ID: 8894513
21. Interaction with indinavir to enhance systemic exposure of an investigational HIV protease inhibitor in rats, dogs and monkeys. Jin L, Chen IW, Chiba M, Lin JH. Xenobiotica; 2003 Jun; 33(6):643-54. PubMed ID: 12851040 [Abstract] [Full Text] [Related]
22. Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor. Wong H, Chen JZ, Chou B, Halladay JS, Kenny JR, La H, Marsters JC, Plise E, Rudewicz PJ, Robarge K, Shin Y, Wong S, Zhang C, Khojasteh SC. Xenobiotica; 2009 Nov; 39(11):850-61. PubMed ID: 19845436 [Abstract] [Full Text] [Related]
23. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. Beconi MG, Reed JR, Teffera Y, Xia YQ, Kochansky CJ, Liu DQ, Xu S, Elmore CS, Ciccotto S, Hora DF, Stearns RA, Vincent SH. Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241 [Abstract] [Full Text] [Related]
25. Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein. Kumar S, Kwei GY, Poon GK, Iliff SA, Wang Y, Chen Q, Franklin RB, Didolkar V, Wang RW, Yamazaki M, Chiu SH, Lin JH, Pearson PG, Baillie TA. J Pharmacol Exp Ther; 2003 Mar; 304(3):1161-71. PubMed ID: 12604693 [Abstract] [Full Text] [Related]
30. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism. Chen Y, Cheng D, Tio C, Kagan N, Eisennagel S, Dasgupta M, Tomczuk B, Bone R, Huebert N. Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144 [Abstract] [Full Text] [Related]
32. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys. Vincent SH, Painter SK, Luffer-Atlas D, Karanam BV, McGowan E, Cioffe C, Doss G, Chiu SH. Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401 [Abstract] [Full Text] [Related]
34. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans. Dalvie D, Cosker T, Boyden T, Zhou S, Schroeder C, Potchoiba MJ. Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038 [Abstract] [Full Text] [Related]
36. Disposition of remoxipride in different species. Species differences in metabolism. Widman M, Nilsson LB, Bryske B, Lundström J. Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [Abstract] [Full Text] [Related]